{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:19Z","timestamp":1790371219878,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003140","name":"Science and Technology Research and Development Program of Shanghai","doi-asserted-by":"publisher","award":["17ZR1403700"],"award-info":[{"award-number":["17ZR1403700"]}],"id":[{"id":"10.13039\/501100003140","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.repc.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T18:07:17Z","timestamp":1605982037000},"page":"723-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Peng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maieryemu","family":"Waresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanqing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2020.07.009_bib0150","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.hlc.2017.05.120","article-title":"Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective","volume":"26","author":"Wong","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.repc.2020.07.009_bib0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/clc.20232","article-title":"Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: retrospective investigation of hospitalized patients","volume":"32","author":"Sun","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.repc.2020.07.009_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8593207","article-title":"Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries","volume":"2017","author":"Ceornodolea","year":"2017","journal-title":"Stroke Res Treatment"},{"key":"10.1016\/j.repc.2020.07.009_bib0165","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.repc.2020.07.009_bib0170","first-page":"258","article-title":"CHADS2 versus CHA2DS2-VASc score in assessing the stroke and throm-boembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"10","author":"Jia-Yuan Chen","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.repc.2020.07.009_bib0295","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/STROKEAHA.118.024305","article-title":"Refining stroke and bleeding prediction in atrial fibrillation by adding consecutive biomarkers to clinical risk scores","volume":"50","author":"Rivera-Caravaca","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2020.07.009_bib0175","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.amjcard.2016.08.069","article-title":"High-sensitivity C-reactive protein and risk of stroke in atrial fibrillation (from the reasons for geographic and racial differences in stroke study)","volume":"118","author":"Dawood","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2020.07.009_bib0180","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jth.13735","article-title":"C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study","volume":"15","author":"Chang","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.repc.2020.07.009_bib0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2020.07.009_bib0190","first-page":"563","article-title":"Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation","volume":"16","author":"Lewicka","year":"2015","journal-title":"Anat J Cardiol"},{"key":"10.1016\/j.repc.2020.07.009_bib0195","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/heartjnl-2015-308887","article-title":"Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation","volume":"102","author":"Hijazi","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.repc.2020.07.009_bib0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.repc.2020.07.009_bib0205","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ahj.2015.09.018","article-title":"Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation","volume":"170","author":"Aulin","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2020.07.009_bib0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2004.01.026","article-title":"Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation","volume":"148","author":"Conway","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2020.07.009_bib0220","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","article-title":"High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"10","author":"Rold\u00e1n","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.repc.2020.07.009_bib0225","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.repc.2020.07.009_bib0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.repc.2020.07.009_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.repc.2020.07.009_bib0240","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.repc.2020.07.009_bib0245","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V74.4.1241.1241","article-title":"Interleukin-6 is a potent thrombopoietic factor in vivo in mice","volume":"74","author":"Ishibashi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.repc.2020.07.009_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/xen.12291","article-title":"Human IL-6, IL-17, IL-1beta, and TNF-alpha differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells","volume":"24","author":"Gao","year":"2017","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.repc.2020.07.009_bib0255","doi-asserted-by":"crossref","first-page":"pe12408","DOI":"10.1111\/xen.12408","article-title":"Porcine IL-6, IL-1beta, and TNF-alpha regulate the expression of pro-inflammatory-related genes and tissue factor in human umbilical vein endothelial cells","volume":"25","author":"Gao","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.repc.2020.07.009_bib0260","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2014.12.024","article-title":"Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis","volume":"135","author":"Bittar","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.repc.2020.07.009_bib0265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00001721-200309000-00001","article-title":"Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis","volume":"14","author":"Chin","year":"2003","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.repc.2020.07.009_bib0270","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0037-1614526","article-title":"Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6","volume":"81","author":"Undar","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.repc.2020.07.009_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2014.09.003","article-title":"Thrombomodulin regulation in human brain microvascular endothelial cells in vitro: role of cytokines and shear stress","volume":"97","author":"Rochfort","year":"2015","journal-title":"Microvasc Res"},{"key":"10.1016\/j.repc.2020.07.009_bib0280","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.hrthm.2010.01.042","article-title":"Atrial platelet reactivity in patients with atrial fibrillation","volume":"7","author":"Willoughby","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.repc.2020.07.009_bib0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcme.2015.01.002","article-title":"A circulating biomarker risk-prediction model correlates with CHADS-2 risk score in chronic atrial fibrillation","volume":"6","author":"Negi","year":"2015","journal-title":"IJC Metab Endocr"},{"key":"10.1016\/j.repc.2020.07.009_bib0290","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s00380-018-01324-7","article-title":"Comparison of anti-inflammatory effects of rivaroxaban vs. dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study): multicenter randomized study","volume":"34","author":"Kikuchi","year":"2019","journal-title":"Heart Vessels"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255120304108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255120304108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:09:11Z","timestamp":1760108951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255120304108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0870255120304108"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2020.07.009","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}